ALX Stock Recent News

ALX LATEST HEADLINES

ALX Stock News Image - zacks.com

ALX, HMN and EBC made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 2, 2025.

zacks.com 2025 Jun 02
ALX Stock News Image - zacks.com

WTKWY and ALX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 2, 2025.

zacks.com 2025 Jun 02
ALX Stock News Image - globenewswire.com

SOUTH SAN FRANCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced that management will participate in the Jefferies 2025 Global Healthcare Conference. Details are as follows:

globenewswire.com 2025 May 30
ALX Stock News Image - zacks.com

ALX and WTKWY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 29, 2025.

zacks.com 2025 May 29
ALX Stock News Image - zacks.com

ALX, ISNPY and EBC made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 29, 2025.

zacks.com 2025 May 29
ALX Stock News Image - zacks.com

ALX, SPFI, BWB, NIC and WTKWY have been added to the Zacks Rank #1 (Strong Buy) List on May 29, 2025.

zacks.com 2025 May 29
ALX Stock News Image - zacks.com

Here is how Alexander's (ALX) and Berkeley Group Holdings PLC Unsponsored ADR (BKGFY) have performed compared to their sector so far this year.

zacks.com 2025 May 27
ALX Stock News Image - globenewswire.com

- A potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors, ALX2004 is uniquely designed with every component optimized to maximize the therapeutic window by reducing toxicity

globenewswire.com 2025 May 20
ALX Stock News Image - globenewswire.com

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced that it will host a webcast event on May 20, 2025, to provide an update on ALX2004, the Company's potentially best- and first-in-class investigational antibody-drug conjugate (ADC). The webcast will highlight the novel mechanism of action, preclinical data and clinical development strategy for ALX2004 following clearance of the Investigational New Drug application from the U.S. Food and Drug Administration earlier this year.

globenewswire.com 2025 May 13
ALX Stock News Image - zacks.com

Alexander's (ALX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

zacks.com 2025 May 08
10 of 50